482 related articles for article (PubMed ID: 18713156)
21. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
22. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
[TBL] [Abstract][Full Text] [Related]
23. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study.
Millán-Guerrero RO; Isais-Millán R; Barreto-Vizcaíno S; Gutiérrez I; Rivera-Castaño L; Trujillo-Hernández B; Baltazar LM
Eur Neurol; 2008; 59(5):237-42. PubMed ID: 18264012
[TBL] [Abstract][Full Text] [Related]
25. Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.
Silberstein SD; Dodick DW; Lindblad AS; Holroyd K; Harrington M; Mathew NT; Hirtz D;
Neurology; 2012 Mar; 78(13):976-84. PubMed ID: 22377815
[TBL] [Abstract][Full Text] [Related]
26. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
27. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
28. Testing the combination beta-blocker plus topiramate in refractory migraine.
Pascual J; Rivas MT; Leira R
Acta Neurol Scand; 2007 Feb; 115(2):81-3. PubMed ID: 17212609
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
Togha M; Malamiri RA; Rashidi-Ranjbar N; Asa S; Mahvelati F; Ashrafi MR
Acta Neurol Belg; 2012 Mar; 112(1):51-5. PubMed ID: 22427290
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
Lewis D; Paradiso E
Headache; 2007; 47(10):1409-17. PubMed ID: 18052950
[TBL] [Abstract][Full Text] [Related]
31. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
[TBL] [Abstract][Full Text] [Related]
32. Topiramate-induced intractable cough during migraine prophylaxis.
Maggioni F; Mampreso E; Mainardi F; Lisotto C; Malvindi ML; Zanchin G
Headache; 2010 Feb; 50(2):301-4. PubMed ID: 19751366
[TBL] [Abstract][Full Text] [Related]
33. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
Krymchantowski AV; Jevoux CC
Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
[TBL] [Abstract][Full Text] [Related]
34. Zonisamide for migraine prophylaxis in patients refractory to topiramate.
Bermejo PE; Dorado R
Clin Neuropharmacol; 2009; 32(2):103-6. PubMed ID: 18978487
[TBL] [Abstract][Full Text] [Related]
35. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
Limmroth V; Biondi D; Pfeil J; Schwalen S
Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
[TBL] [Abstract][Full Text] [Related]
36. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
[TBL] [Abstract][Full Text] [Related]
37. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
39. Topiramate and propranolol for prophylaxis of migraine.
Fallah R; Divanizadeh MS; Karimi M; Mirouliaei M; Shamszadeh A
Indian J Pediatr; 2013 Nov; 80(11):920-4. PubMed ID: 23412986
[TBL] [Abstract][Full Text] [Related]
40. Topiramate in migraine prevention.
Silberstein SD
Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]